Mode
Text Size
Log in / Sign up
N/A N=50 Randomized Double-blind Other

Initial Experience With Storz C-MAC Video Intubation System

Intubation; Difficult

Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Nov 2021
Primary outcome: Primary: Time for Intubation — 12.3; 9.8 seconds

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
C-MAC direct laryngoscopy (Device); C-MAC Indirect laryngoscopy (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The University of Texas Health Science Center, Houston
Primary completion
Sep 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Time for Intubation
12.3; 9.8
SECONDARY
Laryngoscopy Time
8.7; 14.1; 9.1; 12.2
SECONDARY
Airway View at the Time of Laryngoscopy as Categorized by the Modified Cormack-Lehane Classification (Before External Manipulation)
12; 19; 7; 3; 6; 1
SECONDARY
Airway View at the Time of Laryngoscopy as Categorized by the Modified Cormack-Lehane Classification (After External Manipulation)
15; 20; 10; 4; 0; 1
SECONDARY
Number of Participants With Successful Intubation
25; 25
SECONDARY
Ease of Intubation as Assessed by a Rating Scale
14; 16; 6; 4; 4; 4
SECONDARY
Ease of Laryngoscopy as Assessed by a Rating Scale
15; 13; 5; 4; 4; 5

Summary

The purpose of this study is to determine the safety and efficacy of the C-MAC (Karl Storz Endoscopy, Inc., Tuttlingen, Germany) video intubation system guided intubation techniques. We hypothesize that the C-MAC video laryngoscope is safe and efficacious in terms of successful endotracheal intubation. The C-MAC may be a safe and suitable alternative device for routine and difficult laryngoscopy and tracheal intubation. This is the first study to investigate the performance of C-MAC in clinical practice.

Eligibility Criteria

Inclusion Criteria

  • Age 18 - 80 years of age
  • ASA I - III
  • Mallampati I-III
  • Mouthopening > 4cm

Exclusion Criteria

  • Age 80 years of age
  • ASA IV - V
  • Mallampati IV - V
  • Mouthopening < 4cm
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01104090). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search